D.E. Shaw & Co’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-380,000
Closed -$4.35M 4789
2024
Q3
$4.35M Hold
380,000
﹤0.01% 2060
2024
Q2
$4.29M Hold
380,000
﹤0.01% 1974
2024
Q1
$4.22M Hold
380,000
﹤0.01% 2017
2023
Q4
$4.16M Buy
380,000
+300,000
+375% +$3.26M ﹤0.01% 2060
2023
Q3
$864K Hold
80,000
﹤0.01% 3147
2023
Q2
$854K Hold
80,000
﹤0.01% 3172
2023
Q1
$839K Buy
+80,000
New +$831K ﹤0.01% 3276

Other funds holding RENE

D.E. Shaw & Co's RENE Position: Q4 2024 in Review

D.E. Shaw & Co sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 380,000 shares — an estimated $4.35M sold.

D.E. Shaw & Co first reported a position in RENE in Q1 2023 and held it in 7 quarters. The position peaked at $4.35M in Q3 2024. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • D.E. Shaw & Co reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 380,000 Cartesian Growth Corp II shares in Q4 2024, an estimated $4.35M.
  • D.E. Shaw & Co first reported a position in Cartesian Growth Corp II in Q1 2023 and held it in 7 quarters.
  • D.E. Shaw & Co's Cartesian Growth Corp II position peaked at $4.35M in Q3 2024.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.